FDA
approval
· 2022-06-13
FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
FDA approved a supplemental application for buprenorphine from Rhodes Pharmaceuticals L.P., indicating an update to the product's regulatory status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)